Old Web
English
Sign In
Acemap
>
authorDetail
>
Ji H. Kim
Ji H. Kim
City of Hope National Medical Center
Medicine
Temozolomide
Phases of clinical research
Radiation therapy
Radioimmunotherapy
4
Papers
92
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase II trial of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of anaplastic astrocytoma
2013
Journal of Radiation Oncology
Ji H. Kim
Linna Li
Tony S. Quang
Jacqueline Emrich
Theodore E. Yaeger
Joseph M. Jenrette
Steven C. Cohen
Perry Black
Luther W. Brady
Show All
Source
Cite
Save
Citations (4)
Stage I and II Endometrial Adenocarcinoma: Analysis of 2009 FIGO Staging Revision and Impact on Survival by Adjuvant Therapy
2012
International Journal of Radiation Oncology Biology Physics
Ji H. Kim
Timothy E. Schultheiss
Jeffrey Y.C. Wong
Yi-Jen Chen
Show All
Source
Cite
Save
Citations (0)
A Phase II Study of Surgical Excision, Temozolomide, Radiotherapy, and Anti-EGFR Radioimmunotherapy (EXTRA) as Adjuvant Therapy in High-grade Gliomas
2011
International Journal of Radiation Oncology Biology Physics
L.C. Daugherty
S. Morales
b. fisher
L. Li
Ji H. Kim
Tony S. Quang
Jacqueline Emrich
Theodore E. Yaeger
Lydia T. Komarnicky
Luther W. Brady
Show All
Source
Cite
Save
Citations (0)
A Phase II study of anti–epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme
2010
Journal of Neurosurgery
Linna Li
Tony S. Quang
Edward J. Gracely
Ji H. Kim
Jacqueline Emrich
Theodore E. Yaeger
Joseph M. Jenrette
Steven C. Cohen
Perry Black
Luther W. Brady
Show All
Source
Cite
Save
Citations (88)
1